Miljöpåverkan
Milrinon
Miljörisk:
Risk för miljöpåverkan av milrinon kan inte uteslutas då ekotoxikologiska data saknas.
Nedbrytning:
Milrinon är potentiellt persistent.
Bioackumulering:
Milrinon har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (µg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R)
PEC = 5.48*10-6 µg/L
Where:
A = 0.04 kg (total sold amount API in Sweden year 2020, data from IQVIA)
R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 if no data is available.
P = number of inhabitants in Sweden = 10*106
V (L/day) = volume of wastewater per capita and day = 200 ECHA default) (Ref. I)
D = factor of dilution of waste water by surface water flow = 10 ECHA default) (Ref. I)
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
No ecotoxicological test results are available.
Environmental risk classification (PEC/PNEC ratio)
The PEC/PNEC ratio could not be determined since no ecotoxicological test results are available.
According to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), use of milrinone is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) is below the action limit of 0.01 μg/L.
Justification of chosen summary phrases for the environmental risk:
Risk of environmental impact of milrinone cannot be excluded, since no ecotoxicity data are available.
Degradation
Biotic degradation
Ready degradability:
Milrinone is potentially persistent as indicated by a 2.1 % biodegradation in 28 days. (FDA 3.11)
(Ref. II)
Chosen degradation phrase:
Milrinone is potentially persistent.
Bioaccumulation
Partitioning coefficient:
logP = 1.04; 0.33 (predicted (ALOGPS; ChemAxon, respectively)
(Ref. III)
Justification of chosen bioaccumulation phrase:
Since logP < 4, milrinone has low potential for bioaccumulation.
Excretion (metabolism)
Milrinone is mainly excreted in the urine, mainly in unchanged form (83 %) and to a lesser extent as inactive O-glucuronide (12 %). A small amount is excreted via faeces. In healthy subjects, 60 % of the dose was found in the urine within 2 hours supply and within the first 8 hours 90 % were found.
(Ref. IV)
References
-
ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment; find here.
-
Internal report, Sterling Winthrop: Milrinone: CO2 Production Test, March 1992. Report number not available.
-
Milrinone at Drug Bank, retrieved 2021-12-13 from Drug Bank.com; find here
-
SmPC of Corotrop, retrieved 2021-12-13 from SE MPA; find here.